KAIST Develops AI Technology That Predicts and Assembles Cell Drug Responses Like Lego Blocks​
en-GBde-DEes-ESfr-FR

KAIST Develops AI Technology That Predicts and Assembles Cell Drug Responses Like Lego Blocks​


Controlling the state of a cell in a desired direction is one of the central challenges in life sciences, including drug development, cancer treatment, and regenerative medicine. However, identifying the right drug or genetic target for that purpose is extremely difficult. To address this, researchers at KAIST have mathematically modeled the interaction between cells and drugs in a modular “Lego block” manner—breaking them down and recombining them—to develop a new AI technology that can predict not only new cell–drug reactions never before tested but also the effects of arbitrary genetic perturbations.

KAIST (President Kwang Hyung Lee) announced on the 16th of October that a research team led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering has developed a generative AI-based technology capable of identifying drugs and genetic targets that can guide cells toward a desired state.

“Latent space” is an invisible mathematical map used by image-generating AI to organize the essential features of objects or cells. The research team succeeded in separating the representations of cell states and drug effects within this space and then recombining them to predict the reactions of previously untested cell–drug combinations. They further extended this principle to show that the model can also predict how a cell’s state would change when a specific gene is regulated.

The team validated this approach using real experimental data. As a result, the AI identified molecular targets capable of reverting colorectal cancer cells toward a normal-like state, which the team later confirmed through cell experiments.

This finding demonstrates that the method is not limited to cancer treatment—it serves as a general platform capable of predicting various untrained cell-state transitions and drug responses. In other words, the technology not only determines whether or not a drug works but also reveals how it functions inside the cell, making the achievement particularly meaningful.

The research provides a powerful tool for designing methods to induce desired cell-state changes. It is expected to have broad applications in drug discovery, cancer therapy, and regenerative medicine, such as restoring damaged cells to a healthy state.

Professor Kwang-Hyun Cho stated, “Inspired by image-generation AI, we applied the concept of a ‘direction vector,’ an idea that allows us to transform cells in a desired direction.” He added, “This technology enables quantitative analysis of how specific drugs or genes affect cells and even predicts previously unknown reactions, making it a highly generalizable AI framework.”

The study was conducted with Dr. Younghyun Han, Ph.D. candidate Hyunjin Kim, and Dr. Chun-Kyung Lee of KAIST. The research findings were published online in Cell Systems, a journal by Cell Press, on October 15.
※ Paper title: “Identifying an Optimal Perturbation to Induce a Desired Cell State by Generative Deep Learning” (DOI: 10.1016/j.cels.2025.101405)

The study was supported by the National Research Foundation of Korea (NRF) through the Ministry of Science and ICT’s Mid-Career Researcher Program and the Basic Research Laboratory (BRL) Program.

※ Paper title: “Identifying an Optimal Perturbation to Induce a Desired Cell State by Generative Deep Learning” (DOI: 10.1016/j.cels.2025.101405)
Angehängte Dokumente
Regions: Asia, South Korea
Keywords: Applied science, Artificial Intelligence, Technology, Health, Medical, Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement